Clinical trial
An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients…
NCT00257023 · Janssen Pharmaceutical K.K., Industry · Completed
Key facts
| NCT number | NCT00257023 |
|---|---|
| Title | An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia |
| Official title | Exploratory Study of Paliperidone in Patients With Schizophrenia to Investigate the Safety and Efficacy |
| Lead sponsor | Janssen Pharmaceutical K.K., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | paliperidone |
| Enrollment | 52 |
| Start date | Feb 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Nov 22, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: